Search Results - Hungta Chen
- Showing 1 - 9 results of 9
-
1
Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER by Suzanne V. Arnold, Fengming Tang, Andrew Cooper, Hungta Chen, Marilia B. Gomes, Wolfgang Rathmann, Iichiro Shimomura, Jiten Vora, Hirotaka Watada, Kamlesh Khunti, Mikhail Kosiborod
Published in BMC Endocrine Disorders (2022-04-01)Get full text
Article -
2
Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain by Carlos Escobar, Beatriz Palacios, Luis Varela, Martín Gutiérrez, Mai Duong, Hungta Chen, Nahila Justo, Javier Cid-Ruzafa, Ignacio Hernández, Phillip R. Hunt, Juan F. Delgado
Published in BMC Health Services Research (2022-10-01)Get full text
Article -
3
Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain by Carlos Escobar, Beatriz Palacios, Victoria Gonzalez, Martín Gutiérrez, Mai Duong, Hungta Chen, Nahila Justo, Javier Cid-Ruzafa, Ignacio Hernández, Phillip R. Hunt, Juan F. Delgado
Published in BMC Health Services Research (2023-12-01)Get full text
Article -
4
Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study by Markus P Schneider, Navdeep Tangri, Eric Wittbrodt, Toshiki Moriyama, Hungta Chen, Matthew Arnold, Jean Blaise Virgitti, Luca De Nicola, Salvatore Barone, Emily Peach, Krister Järbrink, Pamela Kushner
Published in BMJ Open (2023-05-01)Get full text
Article -
5
WCN24-1574 HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE DISCOVER CKD PROSPECTIVE STUDY by Roberto Pecoits-Filho, Naoki Kashihara, Steven Fishbane, Juan-Jesus Carrero-Roig, Richard Ofori-Asenso, Hungta Chen, Surendra Pentakota, Juan Jose Garcia Sanchez, Eiichiro Kanda, Carol Pollock, David C. Wheeler
Published in Kidney International Reports (2024-04-01)Get full text
Article -
6
High Prevalence of Unrecorded Stage 3 Chronic Kidney Disease in Australia, Brazil, Canada, England, and Spain: The Multinational, Observational REVEAL-CKD Study by Roberto Pecoits-Filho, Kean-Seng Lim, Maria Cristina Ribeiro de Castro, Ana Cebrian, Rafael Santamaria, Naresh Kanumilli, Christian S. Alvarez, Matthew Arnold, Salvatore Barone, Hungta Chen, Krister Järbrink, Navdeep Tangri
Published in International Journal of Clinical Practice (2024-01-01)Get full text
Article -
7
Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme by Peter Fenici, Niklas Hammar, Linong Ji, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Wolfgang Rathmann, Iichiro Shimomura, Marilia B Gomes, Mikhail Kosiborod, Stuart Pocock, Marina V Shestakova, Hungta Chen, Javier Cid-Ruzafa
Published in BMJ Open (2020-08-01)Get full text
Article -
8
Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study by Jesús Medina, Peter Fenici, Linong Ji, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Wolfgang Rathmann, Suzanne V Arnold, Iichiro Shimomura, Mikhail Kosiborod, Hungta Chen, Andrew Cooper, Brenda Bongaerts, Bernard H Charbonnel, Marilia Gomes, Marina Shestakova
Published in BMJ Open Diabetes Research & Care (2021-03-01)Get full text
Article -
9
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program) by Mikhail Kosiborod, Marilia B. Gomes, Antonio Nicolucci, Stuart Pocock, Wolfgang Rathmann, Marina V. Shestakova, Hirotaka Watada, Iichiro Shimomura, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Niklas Hammar, Filip Surmont, Fengming Tang, Kamlesh Khunti, for The DISCOVER investigators
Published in Cardiovascular Diabetology (2018-11-01)Get full text
Article
